PAIGE PITYNSKI: Open Payments
NPI 1407695000 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$692 in 28 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $200 · 2025 $692
Food & beverage: $592Education: $100
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 7 | $250 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $178 |
| Amgen Inc. | 4 | $79 |
| ABBVIE INC. | 2 | $49 |
| Organon LLC | 1 | $22 |
| Incyte Corporation | 1 | $22 |
| PFIZER INC. | 1 | $21 |
| Arcutis Biotherapeutics, Inc. | 1 | $20 |
| Journey Medical Corporation | 1 | $20 |
| UCB, Inc. | 1 | $17 |
Products named: DUPIXENT, OTEZLA, ILUMYA, Winlevi, SKYRIZI, VTAMA, OPZELURA, EUCRISA.
Industry payments across MI — which companies pay providers there.
